Vaccine Overview
Quadrivalent Human Papilloma Virus (Serotypes 6, 11, 16, and 18) Vaccine
This vaccine protects against four major HPV types: 6 and 11, which cause genital warts, and 16 and 18, which are linked to cervical and other cancers. Administered as a series of intramuscular injections, it is recommended for preadolescents and adolescents before sexual activity begins. The recombinant technology ensures high purity and safety. It significantly reduces the risk of HPV-related diseases and is part of many national immunization programs targeting cancer prevention.
Drug Class: Recombinant and other Products
Indication: Prevention of HPV-related diseases, including genital warts (types 6, 11) and cancers (types 16, 18), such as cervical, anal, and oropharyngeal cancers.
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
Before onset of sexual activity (2 or 3 dose schedule)
Administration
Route: Intramuscular
Site: Deltoid muscle of the upper arm
Disease
Human Papillomavirus (genital warts, cervical cancer)
Manufacturer
Serum Intitute Of India
Age
- 9–14 years (2 doses), 15–26 years (3 doses)
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025